Invention Grant
- Patent Title: Tetrahydrobenzothiophene compound
- Patent Title (中): 四氢苯并噻吩化合物
-
Application No.: US13661545Application Date: 2012-10-26
-
Publication No.: US08729068B2Publication Date: 2014-05-20
- Inventor: Shunichiro Hachiya , Masanori Miura , Yoshimasa Imamura , Daisuke Kaga , Ippei Sato , Hiroyuki Moritomo , Koji Kato , Kazuhiro Terai , Yoh Terada
- Applicant: Astellas Pharma Inc.
- Applicant Address: JP Chuo-ku
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Chuo-ku
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2010-104044 20100428
- Main IPC: C07D333/68
- IPC: C07D333/68 ; A61K31/381 ; A61K31/4025 ; A61K31/4436

Abstract:
The purpose is to provide a compound which has an intestinal phosphate transporter (NPT-IIb) inhibitory action and is useful as an active ingredient of an agent for treating and/or preventing hyperphosphatemia.A tetrahydrobenzothiophene compound of the following formula (I) has NPT-IIb inhibitory action and can be used as an agent for treating and/or preventing hyperphosphatemia: wherein, R1 represents —O-lower alkyl, -lower alkylene-phenyl, or the like; R2 and R3 are the same as or different from each other and represent H, lower alkyl, cycloalkyl, aryl, heteroaryl or the like, or, R2 and R3 may be combined with a nitrogen atom to which they bind to form 5- to 7-membered saturated cyclic amino; R4's are the same as or different from each other and represent halogen, lower alkyl; and n represents 0 to 2.
Public/Granted literature
- US20130053369A1 TETRAHYDROBENZOTHIOPHENE COMPOUND Public/Granted day:2013-02-28
Information query